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Introduction
Weight loss is in theory very simple: one 
needs to use up more calories than one 
consumes. It is documented that to lose 
one pound (0.45 kilogram) of body weight 
there needs to be a negative balance of 
3,500 kilocalories (kcal).1 However, in reality 
cutting down excess calories or increasing 
calorie expenditure via exercise might 
prove to be very difficult. Most community 
pharmacists can confirm this by the number 
of clients asking for recommendations 
on weight loss preparations.  As most of 
the over-the-counter (OTC) weight loss 
preparations available on the market in 
Malta are classified as food supplements 
reliable data is lacking. In this paper the 
author has consulted systematic reviews and 
meta-analysis of randomised clinical trials 
of a few common ingredients in weight loss 
preparations available in Malta. 
Citrus Aurantium
Citrus aurantium or bitter orange has 
been studied for weight loss as its primary 
constituent is p-synephrine. P-synephrine 
which is similar in structure to ephedrine is 
thought to increase basal metabolic rate and 
lipolysis as well as acting as a mild appetite 
suppressant. Unfortunately, most of the 
data on p-synephrine is clouded by the lack 
of reproducibility and poorly standardized 
extracts used. In a review of 23 rigorous 
studies published in the International 
Journal of Medical Science it was established 
that bitter orange extract and p-synephrine 
increase metabolism and energy expenditure 
and may contribute to modest weight loss 
if taken for up to 12 weeks in combination 
with dietary and exercise regimens. The loss 
in body weight ranged from 1.04 to 4.63 
kg in the study period but the data was for 
preparations where citrus aurantium was 
only one of the ingredients.5 Side-effects 
commonly associated with ephedrine such as 
high blood pressure and palpitations are not 
to be expected with p-synephrine as it has 
receptor binding specificities. Again, more 
rigorous studies are required to determine 
dose and duration to be recommended for 
significant weight loss.5
Conjugated Linoleic Acid 
Conjugated linoleic acid (CLA) is a collection 
of isomers of linoleic acid, a polyunsaturated 
omega 6 fatty acid which is commonly found 
in dietary sources such as egg yolk, animal 
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Abstract
Obesity has been described as a pandemic as it is estimated to 
contribute to more than 3 million deaths worldwide.2 In Malta 
28.7% of the population is obese and another 67.6% is classified 
as overweight.3, 4 This paper will be provide a summary of 
systematic reviews and meta-analysis of some common ingredients 
in weight loss preparations available in local pharmacies. 
Educational aims
•	 To provide an overview of the main constituents present in commonly used over-the-
counter (OTC) weight loss preparations available in Malta to enable a more knowledge 
based selection
•	 To increase awareness on the efficacy and safety of weight loss preparations
•	 To highlight the limitations of data available on such products
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fats and a number of oils such as peanut oil 
and olive oil. Animal studies have suggested 
that CLA has an effect on body composition 
and in most species it was found to reduce 
body fat. This data fuelled research into 
human studies in the hope that results 
would be reproducible. In a meta-analysis 
published in 2007 which included 20 human 
studies, the authors concluded that CLA 
causes a limited reduction in fat of about 
0.09 kg weekly, around 1 kg every 3 months. 
This loss was not reproducible in all studies 
because efficacy is highly dependent on 
factors such as type of isomer used, dose 
and duration. It has been recommended that 
preparations enriched in c9, t11, and t10, 
c12 isomers are preferable. Although CLA 
is generally safe, its use in patients with 
chronic conditions such as diabetes should 
be monitored more closely as CLA has been 
reported to increase insulin resistance.6 
In another meta-analysis published three 
years ago, which included only studies with 
at least 6 months duration, the authors 
revealed a small significant difference in 
fat loss favouring CLA over placebo. The 
loss was of 0.7kg which was thought by 
the authors to be too small to have a 
clinically relevant effect on long term body 
composition. Adverse events reported in this 
review included constipation and diarrhoea.7 
Therefore although CLA is relatively safe and 
has a beneficial effect, this may be too low 
to justify its cost. 
Garcinia Cambogia
Garcinia Cambogia is a tropical fruit 
high in hydroxycitric acid (HCA). There 
are various claims on how HCA actually 
causes weight loss, most of which come 
from animal studies. The most popular is 
that HCA inhibits the enzyme adenosine 
triphosphatase-citrate-lyase, which in 
laymen’s terms is the fat producing enzyme. 
Others report that HCA increases the release 
or availability of serotonin in the brain, 
thus leading to appetite suppression.  Other 
theories on its mechanism of action include 
the inhibition of pancreatic alpha amylase 
and intestinal alpha glucosidase responsible 
for carbohydrate metabolism. In a systematic 
review published in Journal of Obesity, the 
authors concluded that the overall efficacy 
is minimal to be of clinical relevance when 
taking into consideration well-designed 
human studies.8 It is also still undetermined 
what the recommended dose should be as it 
varied significantly from 1 g to 2.8 g daily8. 
Duration of treatment is also uncertain and 
could be limited by adverse effects such as 
gastrointestinal disturbances and headaches. 
In summary, it seems that although some 
studies have shown that HCA may generate 
weight loss, this is too minimal for 
recommending it to the general public and 
more research is necessary.
Green Tea Extract with or without Caffeine 
There are numerous catechins found in green 
tea extract, the most important of which 
is believed to be epigallocatechin gallate 
(EGCG) which is involved in the inhibition of 
adipocyte differentiation and proliferation, 
reduced fat absorption, inhibition of 
catecho-o-methyl transferase, increased 
energy expenditure and increased utilization 
of fat.9 It also has natural caffeine which 
has been reversibly associated with weight 
gain probably due to its known thermogenic 
effects and increase energy expenditure.10 In 
a systematic review and meta-analysis which 
evaluated data from 15 trials it was reported 
that over a 12-week period those who 
ingested a median of 588mg daily of green 
tea catechins (GTCs) with caffeine compared 
with dose who drank caffeine alone had a 
statistically significant weight loss of around 
1.38kg and an average reduction in waist 
circumference of 1.93 cm.  A statistically 
significant 0.44 kg weight loss was observed 
in a group of individuals ingesting GTC with 
caffeine compared to a caffeine free control 
group. These results seem to indicate that 
there is synergism between GTC and caffeine, 
as studies evaluating GTC administration 
on its own showed no benefits in weight 
loss.  Safety concerns with GTCs are minimal; 
although there were some reports of liver 
dysfunction, these were not sustained 
when investigated for short-term use.9 Yet 
the authors of this meta-analysis stated 
that despite the significant results, for 
pharmacologic weight loss products, patients 
are considered to have failed treatment if 
they have not achieved a loss of 2 kg after 4 
weeks of therapy,9 which as one can deduce, 
is well beyond the results provided with GTC 
and caffeine administration.  
Guarana 
Guarana is a plant which contains caffeine, 
theophylline and theobromide and thus 
has been incorporated as a stimulant into 
weight loss and nutritional supplements as it 
enhances athletic performance and reduces 
mental and physical fatigue.11 There are no 
studies which have looked at the isolated 
effect of guarana however there are studies 
in combination with yerba mate, Ma Huang 
(ephedra) and Damiana. In a small study in 
combination with Ma Huang, it was found 
that over an eight-week period, subjects had 
an average weight loss of 4 kg compared to 
the group receiving placebo, with minimal 
adverse symptoms reported. In a double-
blind randomised trial study investigating 
a product containing extracts of Yerba 
Mate, Guarana and Damiana for 45 days, 
researchers reported a weight loss of 5.1 
kg compared with only 0.3 kg in the group 
given placebo. In a post-marketing research, 
a small group of 48 patients were followed 
up for 28 days and self-reported a mean loss 
of 2.3 kg in body weight.12 Although the 
loss in weight was significant the sample 
size were small and thus it is difficult 
to extrapolate the data to the general 
population, yet at least this combination 
seems to have some potential. 
Orlistat
Orlistat is a specific, potent and long-
acting inhibitor of gastrointestinal lipases. 
It forms a covalent bond with around 30% 
of the active serine site of gastric and 
pancreatic lipases inactivating them so that 
they are unavailable to hydrolyse dietary 
fat into absorbable free fatty acids and 
monoglycerides.13 Orlistat was originally 
marketed as a prescription only medicine 
(POM) but a few years later the reduced 
dose was available as an OTC preparation. 
In 2003 a Cochrane meta-analysis which 
included eight randomized double blinded 
trials revealed that the drug was modestly 
effective in promoting weight loss.14 An 
update review published a few years later 
concluded that orlistat was associated with 
a weight loss of around 3% more than diet 
alone in overweight and obese people. 
Orlistat 120mg administered three times 
daily contributed to a 2.7 kg weight loss 
more than diet alone. The period of time 
over which this loss was observed was not 
specified. In a 2014 meta-analysis which 
pooled data from 45 studies reported that 
patients on orlistat 120mg three times 
daily had a mean loss of 2.34 kg whereas 
patients on 60mg or 30mg three times daily 
had a mean loss of 0.7 kg. This loss was 
maintained after 18 and 36 months. Adverse 
events reported with orlistat are directly 
related to its mode of action and refer to 
gastrointestinal events.15 Orlistat was also 
studied in patients with type-2 diabetes 
and non-alcoholic fatty liver disease 
(NAFLD) with good preliminary results of 
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improvement in glycaemic control, lower 
cholesterol and blood pressure values.16 It is 
suggested that orlistat is only cost effective 
in those achieving at least 5% weight 
loss after 3 months16 and this is the same 
threshold the company adopts for cessation 
of treatment.13 
Conclusion
Most of the products available locally seem 
to contain different dosages of a number 
of the above mentioned ingredients, some 
even combined with other ingredients. 
It is difficult to say whether combining 
such ingredients would have an additive 
or synergistic effect or whether this would 
mean having more significant adverse 
events. Most of the studies on individual 
preparations seem to be flawed in their 
design and usually come from the company 
marketing the product which introduces an 
element of bias. As health care professionals 
we need to offer the correct advice being 
mindful that the product may provide 
minimal benefit
Key points
•	 To lose one kilogram (kg) in body weight there has to be a deficit of approximately 
7,000 kilocalories.1
•	 Most weight loss products available on the market lack rigorous evidence to back up 
their claims.
•	 Weight loss products should always be recommended as an adjunct to healthy diet 
and regular exercise.
•	 Low-dose orlistat is the only OTC preparation approved by the Food and Drug 
Administration and the European Medicines Agency available in Malta. 
•	 Extra caution needs to be taken in patients who are overweight or obese and 
who have additional co-morbidities such as diabetes and cardiovascular events, 
since most of the products reviewed below have not been investigated in these 
populations.
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